fbpx

Not what you are looking for?,

Search Close
INSIGHT temporary hero - resized INSIGHT temporary hero - resized
Sep 9-12 | From Science to Implementation

INSIGHT Conference 2021

Psychedelic states in basic research, therapy, and human development

Learn more

New: APT – Augmented Psychotherapy Training

Do you want to train as a psychedelic therapist or co-therapist? MIND’s three-year training program provides you with the knowledge and skills to practice in a legal, safe, and evidence-based framework.

Read more

 

About Us

The MIND Foundation is a European non-profit science and education organization that promotes psychedelic research and therapy. Our work builds on the neurobiological and psychological potential of psychedelics to improve mental health and well-being in a clinical setting; for which the scientific base is firmly growing.

Learn more
HomePage_About Us

MIND Academy

The MIND Academy is the MIND Foundation’s educational platform for learning about psychedelic science and therapy. The MIND Academy offers trainings, workshops, public talks, and experiences. The Academy aims to educate the public, train professionals in the medical and psychotherapeutic fields, and shape a scientific discourse around altered states of consciousness and the psychedelic experience.

Learn more
HomePage_MIND Academy

Research

The MIND Foundation is dedicated to contributing to high-quality psychedelic research. Our team is involved in a psilocybin depression study in Germany. We also work at the university level with scientists and students to enable research and networking opportunities via a variety of programs and resources. 

Learn more
HomePage_Research

Scientific Advisory Board

The MIND Foundation is advised by a panel of leading academic researchers. They are thinkers dealing with the human brain and consciousness, the transformation of society, psychiatric disorders, and the sociocultural history of the psychedelic experience.

Learn more
HomePage_SAB
 
  • Essay
  • Drug Science
The Future of Psychedelics in Alzheimer’s Disease Treatment

Will the latest psychedelics research usher in a more hopeful era for patients with neurodegenerative conditions such as Alzheimer's?

Milena Marinković
•
 
  • News
  • MIND News
INSIGHT Conference 2021: Clarity and Depth

INSIGHT 2021 is a psychedelic research and education conference to discuss questions towards the advancement of a culture and ethics of consciousness.

Dr. Henrik Jungaberle
•
 
  • Interview
  • Biochemistry
Neurobiology of Antidepressant Drugs

Research suggests that many classical and novel antidepressants may share a common neurobiological mechanism.

Prof. Eero Castrén Lukas Basedow, M.Sc.
•
View More

Our partners

ovid
zentralinstitu
Charite auf MIND Website
usona

See all

MIND MEMBERSHIP

Becoming a MIND member means joining a community of like-minded individuals interested in advancing psychedelic research and education, thereby promoting a culture of consciousness or Bewusstseinskultur. MIND members enjoy many benefits, from discounts on MIND Academy events to networking opportunities and access to high-quality online content.

The MIND Members Association offers professional development for medical doctors, psychotherapists, and related fields – and we have memberships for students and friends. Take a look at our lively Professional Sections, the Forum, the Members Convention, the workshops and members talks, and more. This is a science-based community rapidly developing. It is in an active relationship with universities and engaged in the renewal of psychiatric and psychotherapeutic treatments, human development, and critical dialogue to advance society. We are international, European, and German.

Become a member

Clinical Partner

OVID Health Systems

OVID is the MIND Foundation’s sister organization, providing the medical, educational, and scientific infrastructure for the application of psychedelic treatments.

OVID Website

MIND Foundation
Newsletter

Sign up for our newsletter and we’ll keep you up to date with everything to do with the MIND Foundation.